close
close

Company logo

US immunoassay market

US immunoassay marketUS immunoassay market

US immunoassay market

Dublin, July 11, 2024 (GLOBE NEWSWIRE) — The report “US Immunoassay Market Size, Share & Trends Analysis Report by Product (Reagent & Kits, Analyzers/Instruments), Technology (RIA, ELISA), Application, Specimen, End-use, Region, and Segment Forecasts, 2024-2030” has been added to The Offer.

The US immunoassay market is expected to reach $12.25 billion by 2030, growing at a compound annual growth rate of 2.8% from 2024 to 2030.

Increasing incidence of chronic and infectious diseases and increasing demand for early detection of diseases are the major factors contributing to the market growth. According to the International Agency for Research on Cancer, 19,292,789 cases of cancer were reported in 2020 and 50,550,287 cases are expected to be reported by 2025. Breast, lung, colon, prostate and stomach cancer are the most commonly reported types of cancer.

The rising number of elderly people is a major growth factor for the US market. As more people reach retirement age and require medical care, the demand for diagnostic tests such as immunoassays is expected to rise. In addition, technological advancements such as automation, miniaturization, point-of-care testing devices, and advanced detection technologies are key drivers of the immunoassay market. These innovations have revolutionized immunoassay techniques, making them more efficient, reliable, and accessible for a wide range of healthcare and research applications.

The increasing use of immunoassay tests in clinical diagnostics and research laboratories has positively impacted the U.S. market by driving market expansion, encouraging innovation in assay development, and improving patient outcomes through early and accurate diagnosis.

Highlights of the US Immunoassay Market Report

  • Reagents and kits led the market with the largest revenue share of 65.82% in 2023 and are expected to grow at the fastest CAGR during the forecast period due to the increasing adoption and approval of innovative immunoassay kits.

  • Based on application, the infectious disease testing segment led the market with the largest revenue share of 29.55% in 2023, due to the increasing demand for immunoassays for early detection of infectious diseases such as HIV, hepatitis, COVID-19 and others

  • Based on end use, hospital segments held the market with the largest revenue share of 33.01% in 2023. Hospitals are considered as primary healthcare facilities for diagnosing various diseases, which drives the segment growth

  • Based on samples, the blood segment led the market with the largest revenue share of 43.19% in 2023, owing to the increasing incidence of diseases requiring these blood testing procedures and technological advancements in this segment.

  • In July 2023, SEKISUI Diagnostics launched the US-made OSOM COVID-19 Antigen Home Test. The test can be performed at home and likely helps detect the nucleocapsid protein antigen derived from the SARS-CoV-2 virus.

Featured companies

Key Features:

Report Attribute

details

Number of pages

70

Forecast period

2023 – 2030

Estimated market value (USD) in 2023

10.31 billion US dollars

Projected market value (USD) until 2030

12.25 billion US dollars

Annual growth rate

2.8%

Regions covered

United States

Main topics covered:

Chapter 1. Methodology and scope

Chapter 2. Summary
2.1. Market outlook
2.2. Segment outlook
2.3. Insights into the competition

Chapter 3. US Immunoassay Market Variables, Trends and Scope
3.1. Market outlook
3.1.1. Outlook for the parent market
3.1.2. Related/complementary market outlook
3.2. Market dynamics
3.2.1. Market driver analysis
3.2.2. Market restriction analysis
3.3. Analysis tools for the US immunoassay market
3.3.1. Industry analysis – Porter's
3.3.2. PESTEL analysis

Chapter 4. US Immunoassay Market: Product Estimates and Trend Analysis
4.1. Product market share, 2023 and 2030
4.2. Segment Dashboard
4.3. US immunoassay market by product outlook
4.4. Market size & forecasts and trend analysis, 2018 to 2030 for the following
4.4.1. Reagents and kits
4.4.1.1. Market estimates and forecasts, 2018 to 2030 (in million USD)
4.4.1.2. ELISA reagents and kits
4.4.1.3. Reagents and kits for rapid tests
4.4.1.4. ELISPOT reagents and kits
4.4.1.5. Western blot reagents and kits
4.4.2. Analyzers/Instruments
4.4.2.1. Market estimates and forecasts, 2018 to 2030 (in million USD)
4.4.2.2. Open systems
4.4.2.3. Closed systems
4.4.3. Software and services

Chapter 5. US Immunoassay Market: Technology Estimates and Trend Analysis
5.1. Technology market share, 2023 and 2030
5.2. Segment Dashboard
5.3. US immunoassay market by technology outlook
5.4. Market size & forecasts and trend analysis, 2018 to 2030 for the following
5.4.1. Radioimmunoassay (RIA)
5.4.2. Enzyme immunoassays (EIA)
5.4.2.1. Market estimates and forecasts, 2018 to 2030 (in million USD)
5.4.2.2. Chemiluminescence immunoassays (CLIA)
5.4.2.3. Fluorescence immunoassays (FIA)
5.4.3. Rapid test

Chapter 6. US Immunoassay Market: Application Estimates and Trend Analysis
6.1. Application market share, 2023 and 2030
6.2. Segment Dashboard
6.3. US Immunoassay Market by Application Outlook
6.4. Market size & forecasts and trend analysis, 2018 to 2030 for the following
6.4.1. Therapeutic drug monitoring
6.4.2. Oncology
6.4.3. Cardiology
6.4.4. Endocrinology
6.4.5. Tests for infectious diseases
6.4.6. Autoimmune diseases

Chapter 7. US Immunoassay Market: End-use Estimates and Trend Analysis
7.1. End-user market share, 2023 and 2030
7.2. Segment Dashboard
7.3. US Immunoassay Market by End-User Outlook
7.4. Market size & forecasts and trend analysis, 2018 to 2030 for the following
7.4.1. Hospitals
7.4.2. Blood banks
7.4.3. Clinical laboratories
7.4.4. Pharmaceutical and biotech companies
7.4.5. Academic research centres

Chapter 8. US Immunoassay Market: Sample Estimates and Trend Analysis
8.1. Example of market shares, 2023 and 2030
8.2. Segment Dashboard
8.3. US immunoassay market by sample outlook
8.4. Market size & forecasts and trend analysis, 2018 to 2030 for the following
8.4.1. Blood
8.4.2. Saliva
8.4.3. Urin
8.4.4. Other samples

Chapter 9. US Immunoassay Market: Regional Estimates and Trend Analysis
9.1 Regional market share, 2023 and 2030
9.2. Outlook for the US Immunoassay Market by Region
9.3. Market size & forecasts and trend analysis, 2018 to 2030 for the following
9.3.1. West
9.3.2. Midwest
9.3.3. Northeast
9.3.4. Southwest
9.3.5. Southeast

Chapter 10. Competitive landscape
10.1. Current developments and impact analysis by key market participants
10.2. Categorization of companies/competitors
10.3. Provider landscape
10.3.1. List of key distributors and sales partners
10.3.2. Key customers
10.3.3. Heatmap analysis of the most important companies, 2023
10.4. Company profiles
10.4.1. Company overview
10.4.2. Financial performance
10.4.3. Product benchmarking
10.4.4. Strategic initiatives

For more information about this report visit https://www.researchandmarkets.com/r/w5wzsi

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source of international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Leave a Reply

Your email address will not be published. Required fields are marked *